• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $LFST

    LifeStance Health Group Inc.

    Subscribe to $LFST
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.

    IPO Year: 2021

    Exchange: NASDAQ

    Website: lifestance.com

    Recent Analyst Ratings for LifeStance Health Group Inc.

    DatePrice TargetRatingAnalyst
    5/27/2025$8.50Neutral → Buy
    UBS
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    5/15/2023$8.00 → $9.00Outperform → Market Perform
    TD Cowen
    1/6/2023$8.00Equal-Weight → Overweight
    Morgan Stanley
    11/7/2022$7.25Buy
    Jefferies
    3/17/2022$19.00 → $10.00Buy → Neutral
    UBS
    12/17/2021$15.00 → $10.00Equal-Weight
    Morgan Stanley
    See more ratings